Home » Topics » Conferences

Conferences
RSS

Etifoxine compared to buspirone for adjustment disorder with anxiety

July 4, 1997

Exocell presents new small-molecule antiglycation agent

July 4, 1997

Selective 5-HT1D receptor agonist active in two migraine models

July 4, 1997

Novel antifibrillatory agent: DP-16

July 3, 1997

ReoPro safe and effective in high-risk PTCA patients

July 1, 1997

New hypoglycemic/insulin-sensitizing agent from Novartis

July 1, 1997

Endothelin antagonist protects against indomethacin-induced gastric damage

July 1, 1997

Baxter's DCLHb safe in acute ischemic stroke patients

June 27, 1997

SKB discovers first selective human 5-HT1B receptor ligand

June 27, 1997

Novel anxiolytic and antidepressant buspirone analogue characterized

June 27, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...
Deerfield-backed Boulevard, Metis pen $1.6B trispecific TCE deal
BioWorld
A U.S. biotechnology company founded by Deerfield Management Company L.P. licensed exclusive rights to Metis Techbio Co. Ltd.’s preclinical trispecific T-cell...
CINP 2026: organoids reveal autism and addiction mechanisms
BioWorld Science
At the 2026 World Congress of Neuropsychopharmacology (CINP), held in Glasgow June 26-29, 2026, researchers from Japan’s National Center of Neurology and...